CVAC240517P2500
- 0.05
- 0.000.00%
CureVac Newsroom
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don't Count Your Chicks -- WSJ
By David Wainer Vaccine stocks are back in vogue, at least for now. Moderna, BioNTech, CureVac and Novavax have added billions of dollars in combined market capitalization gains in recent days after
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
JMP Securities Maintains CureVac(CVAC.US) With Buy Rating, Maintains Target Price $18
JMP Securities analyst Roy Buchanan maintains $CureVac(CVAC.US)$ with a buy rating, and maintains the target price at $18.According to TipRanks data, the analyst has a success rate of 33.0% and a tota
Buy Rating on CureVac: Positive Financial Outlook and Promising Vaccine Trials Fuel Optimism
Express News | CureVac's Cash And Cash Equivalents Position Of €300.2M As Of March 31, 2024; Reaffirming Cash Runway Into Fourth Quarter Of 2025
Express News | CureVac Reported Q1 2024 Pre-Tax Loss Of €69.9M Vs. €57.4M YoY
CureVac Q1 2024 Sales €12.400M Beat €12.030M Estimate
CureVac Q1 2024 Sales €12.400M Beat €12.030M Estimate
Moderna, CureVac, Other Vaccine Stocks Jump as New Human Bird-flu Cases Reported in U.S., Australia
Vaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in the U.S. and Australia.
The spread of avian influenza sparks fears that US vaccine stocks such as Moderna (MRNA.US) rose sharply
US vaccine stocks rose sharply on Wednesday.
Moderna, BioNTech Close With Double-digit Percentage Gains Amid Bird Flu Fears
Health Care Up as Vaccine Makers Gain - Health Care Roundup
Health-care companies rose as reported cases of bird flu in Australia and the U.S. buoyed vaccine makers. Shares of CureVac, BioNTech and Moderna rose by 10% or more after new human bird-flu cases we
CureVac Up Over 23%, on Pace for Largest Percent Increase Since January 2023 -- Data Talk
CureVac N.V. ( CVAC ) is currently at $4.05, up $0.76 or 23.1% --Would be highest close since Jan. 8, 2024, when it closed at $4.24 --On pace for largest percent increase since Jan. 9, 2023, when it
COVID-19 Vaccine Makers Rebound Amid Post-pandemic Prospects
CureVac, Oragenics, IGM Biosciences Among Healthcare Movers
Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed, with the Dow Jones gaining around 0.1% on Friday.Shares of Despegar.com, Corp. (NYSE:DESP) rose sharply during Friday's session after the company reported better-than-expected
Deutsche Numis Keeps Their Hold Rating on CureVac (CVAC)
Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Revance Therapeutics (RVNC) and CureVac (CVAC)
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Tesla CEO Elon Musk does not seem to agree with Republicans at least on one thing. On Wednesday, the billionaire, true to his credentials as a tech pioneer, unequivocally backed the mRNA technology, w
Express News | CureVac : Deutsche Bank Cuts Target Price to $6.5 From $8
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday.Shares of Spirit Airlines, Inc. (NYSE:SAVE) fell sharply during Monday's session as the company reported a first-qu